Pfizer Vaccine Approved for Children Ages 5-11

Since November 2, 2021, children aged 5-11 have been eligible to receive the Pfizer COVID-19 vaccine.

On October 29, the Food and Drug Administration (FDA) approved the vaccine for children in this age range, and it took just four more days for the Center of Disease Control (CDC) to follow suit. The first vaccines for ages 5-11 were distributed on November 3, and as of November 10, nearly one million 5-11 year olds have received their first dose of the COVID vaccine.

According to testing by the FDA, this vaccine is 90.7% effective in preventing COVID infections in children, which is about twice as effective as the flu vaccine. During the trial stages, three cases of COVID were reported in 1,305 newly vaccinated children, while in 663 placebo (fake) shot recipients, there were sixteen reported cases.

Although children are at lower risk for COVID-19 than adults, 1.8 million cases have been reported for 5-11 year olds in the United States. Nearly one hundred children in this age group have died from COVID. Additionally, the risk of developing Multisystem Inflammatory Syndrome, a disease that causes severe inflammation of organs and is allegedly related to COVID, is the highest for these children.

Children also receive ⅓ of the dosage that adults do, which reduces harmful side effects. COVID shots are free and provided by pediatric services and vaccination companies. The vaccine is a safe way to keep children healthy.